Paquette M - Search Results

1

Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.

Newman DM, Dorian P, Paquette M, Sulke N, Gold MR, Schwartzman DS, Schaaf K, Wood K, Johnson L; Worldwide Jewel AF AF-Only Investigators. Newman DM, et al. Among authors: paquette m. Am Heart J. 2003 May;145(5):841-6. doi: 10.1016/S0002-8703(02)94817-9. Am Heart J. 2003. PMID: 12766741

2

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.

Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, Roy D. Dorian P, et al. Among authors: paquette m. Am Heart J. 2002 Jun;143(6):984-90. doi: 10.1067/mhj.2002.122518. Am Heart J. 2002. PMID: 12075253 Clinical Trial.

3

Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing.

Newman D, Lau C, Tang AS, Irvine J, Paquette M, Woodend K, Dorian P, Gent M, Kerr C, Connolly SJ; CTOPP Investigators. Newman D, et al. Among authors: paquette m. Am Heart J. 2003 Mar;145(3):430-7. doi: 10.1067/mhj.2003.167. Am Heart J. 2003. PMID: 12660665 Clinical Trial.

4

Is inappropriate implantable defibrillator shock therapy predictable?

Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, Noble J, Newman D. Nanthakumar K, et al. Among authors: paquette m. J Interv Card Electrophysiol. 2003 Jun;8(3):215-20. doi: 10.1023/a:1023973306742. J Interv Card Electrophysiol. 2003. PMID: 12815308

5

Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators.

Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, Gilkerson J, Greene M, Heng D, Dorian P. Nanthakumar K, et al. Among authors: paquette m. Am Heart J. 2000 May;139(5):797-803. doi: 10.1016/s0002-8703(00)90010-3. Am Heart J. 2000. PMID: 10783212

6

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C, Dorian P. Paquette M, et al. Am J Cardiol. 2000 Oct 1;86(7):764-8. doi: 10.1016/s0002-9149(00)01077-8. Am J Cardiol. 2000. PMID: 11018197 Clinical Trial.

7

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B. Dorian P, et al. Among authors: paquette m. J Am Coll Cardiol. 2000 Oct;36(4):1303-9. doi: 10.1016/s0735-1097(00)00886-x. J Am Coll Cardiol. 2000. PMID: 11028487 Free article. Clinical Trial.

8

Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.

Pinter A, Dorian P, Paquette M, Ng A, Burns M, Spanu I, Freeman M, Korley V, Newman D. Pinter A, et al. Among authors: paquette m. J Cardiovasc Pharmacol Ther. 2003 Mar;8(1):17-24. doi: 10.1177/107424840300800i104. J Cardiovasc Pharmacol Ther. 2003. PMID: 12652326 Clinical Trial.

9

Systematic evaluation of the determinants of defibrillation efficacy.

Nanthakumar K, Newman D, Paquette M, Dorian P. Nanthakumar K, et al. Among authors: paquette m. Heart Rhythm. 2005 Jan;2(1):36-41. doi: 10.1016/j.hrthm.2004.10.028. Heart Rhythm. 2005. PMID: 15851263

10

Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.

Nanthakumar K, Newman D, Paquette M, Greene M, Rakovich G, Dorian P. Nanthakumar K, et al. Among authors: paquette m. Am Heart J. 1997 Oct;134(4):752-7. doi: 10.1016/s0002-8703(97)70060-7. Am Heart J. 1997. PMID: 9351744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters